Your browser doesn't support javascript.
loading
Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Miyazaki, Isao; Odintsov, Igor; Ishida, Keiji; Lui, Allan J W; Kato, Masanori; Suzuki, Tatsuya; Zhang, Tom; Wakayama, Kentaro; Kurth, Renate I; Cheng, Ryan; Fujita, Hidenori; Delasos, Lukas; Vojnic, Morana; Khodos, Inna; Yamada, Yukari; Ishizawa, Kota; Mattar, Marissa S; Funabashi, Kaoru; Chang, Qing; Ohkubo, Shuichi; Yano, Wakako; Terada, Ryuichiro; Giuliano, Claudio; Lu, Yue Christine; Bonifacio, Annalisa; Kunte, Siddharth; Davare, Monika A; Cheng, Emily H; de Stanchina, Elisa; Lovati, Emanuela; Iwasawa, Yoshikazu; Ladanyi, Marc; Somwar, Romel.
Afiliación
  • Miyazaki I; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan. isao-miyazaki@taiho.co.jp.
  • Odintsov I; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ishida K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lui AJW; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Kato M; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • Suzuki T; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhang T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Wakayama K; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • Kurth RI; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • Cheng R; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Fujita H; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • Delasos L; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Vojnic M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Khodos I; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • Yamada Y; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ishizawa K; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Mattar MS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Funabashi K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chang Q; Northwell Health Cancer Institute, Lenox Hill Hospital, New York, NY, USA.
  • Ohkubo S; Antitumor Assessment Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yano W; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • Terada R; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Giuliano C; Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, Japan.
  • Lu YC; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Bonifacio A; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • Kunte S; Antitumor Assessment Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Davare MA; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • Cheng EH; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • de Stanchina E; Taiho Pharmaceutical Co. Ltd., Tsukuba, Japan.
  • Lovati E; Helsinn Healthcare SA, Lugano, Switzerland.
  • Iwasawa Y; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ladanyi M; Helsinn Healthcare SA, Lugano, Switzerland.
  • Somwar R; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Cancer ; 4(10): 1526, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37814012
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: Japón